Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Tatsumi · SciRah

Researcher profile · Semantic Scholar

T. Tatsumi

Share profile

T. Tatsumi — researcher profile on SciRah

h-index: 57
Works: 311
Citations: 11K

Most-cited papers

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma
Hiroki Murai, T. Kodama, K. Maesaka, S. Tange +26 more
2022Hepatology141 citations Open access
Semantic Scholar
Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
K. Kozumi, T. Kodama, Hiroki Murai, Sadatsugu Sakane +16 more
2021Hepatology141 citations Open access
Semantic Scholar
Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production.
Yuta Myojin, Hayato Hikita, M. Sugiyama, Yoichi Sasaki +15 more
2020Gastroenterology134 citations Open access
Semantic Scholar
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
Yuta Myojin, T. Kodama, R. Sakamori, K. Maesaka +16 more
2022Cancers84 citations Open access
Semantic Scholar
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
Takayuki Matsumae, T. Kodama, Yuta Myojin, K. Maesaka +20 more
2022Cancers70 citations Open access
Semantic Scholar
White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
Sadatsugu Sakane, Hayato Hikita, K. Shirai, Yuta Myojin +11 more
2021Cellular and Molecular Gastroenterology and Hepatology61 citations Open access
Semantic Scholar
ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma
Yuta Myojin, T. Kodama, K. Maesaka, Daisuke Motooka +12 more
2020Clinical Cancer Research59 citations Open access
Semantic Scholar
Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non–Cell Autonomous Liver Carcinogenesis
Yuki Makino, Hayato Hikita, K. Fukumoto, Hyun Sung Ji +9 more
2022Cancer Research54 citations Open access
Semantic Scholar
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
K. Maesaka, R. Sakamori, Ryoko Yamada, Akira Doi +12 more
2022Hepatology Research51 citations
Semantic Scholar
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
Y. Tahata, Hayato Hikita, S. Mochida, N. Kawada +29 more
2020Journal of gastroenterology50 citations
Semantic Scholar
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
K. Maesaka, R. Sakamori, Ryoko Yamada, Y. Tahata +11 more
2021Hepatology Research41 citations
Semantic Scholar
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
Y. Tahata, Hayato Hikita, S. Mochida, N. Enomoto +32 more
2022Journal of gastroenterology36 citations
Semantic Scholar
Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response
Ryoko Yamada, N. Hiramatsu, T. Oze, Ayako Urabe +23 more
2019Hepatology Research33 citations
Semantic Scholar
Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination
Yuta Myojin, Hayato Hikita, Y. Tahata, Akira Doi +21 more
2021Alimentary Pharmacology and Therapeutics28 citations
Semantic Scholar
Dysregulation of PI3K and hippo signaling pathways synergistically induces chronic pancreatitis via Ctgf upregulation.
Takeshi Tamura, T. Kodama, Katsuhiko Sato, Kazuhiro Murai +12 more
2021Journal of Clinical Investigation28 citations Open access
Semantic Scholar
Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels
Katsuhiko Sato, Hayato Hikita, Yuta Myojin, K. Fukumoto +11 more
2020PLoS ONE26 citations Open access
Semantic Scholar
Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation
Yuto Shiode, Hayato Hikita, Satoshi Tanaka, Kumiko Shirai +12 more
2020Scientific Reports26 citations Open access
Semantic Scholar
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
K. Maesaka, R. Sakamori, Ryoko Yamada, Akira Doi +23 more
2023PLoS ONE25 citations Open access
Semantic Scholar
STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression
Yuki Makino, Hayato Hikita, S. Kato, M. Sugiyama +15 more
2022Cellular and Molecular Gastroenterology and Hepatology25 citations Open access
Semantic Scholar
TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation
Yuto Shiode, T. Kodama, Satoshi Shigeno, Kazuhiro Murai +13 more
2022Hepatology25 citations Open access
Semantic Scholar
Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway
Kazuhiro Murai, Hayato Hikita, Yugo Kai, Y. Kondo +15 more
2020Scientific Reports25 citations Open access
Semantic Scholar
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
Tomohide Kurahashi, Yuichi Yoshida, S. Ogura, M. Egawa +14 more
2019Cellular and Molecular Gastroenterology and Hepatology25 citations Open access
Semantic Scholar
Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct‐acting anti‐virals
Y. Tahata, R. Sakamori, Ryoko Yamada, T. Kodama +17 more
2021Alimentary Pharmacology and Therapeutics24 citations
Semantic Scholar
Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment
Y. Tahata, R. Sakamori, Ayako Urabe, Ryoko Yamada +9 more
2020Hepatology Research23 citations
Semantic Scholar
Soluble UL16-binding protein 2 is associated with a poor prognosis in pancreatic cancer patients.
Tadashi Kegasawa, T. Tatsumi, Teppei Yoshioka, T. Suda +8 more
2019Biochemical and Biophysical Research Communications - BBRC22 citations
Semantic Scholar
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis
Y. Tahata, R. Sakamori, Ryoko Yamada, T. Kodama +19 more
2022Hepatology Research21 citations
Semantic Scholar
Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions
Teppei Yoshioka, Minoru Shigekawa, K. Ikezawa, Takeshi Tamura +8 more
2020Pancreas21 citations
Semantic Scholar
Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis
Shusuke Kumazaki, Hayato Hikita, Y. Tahata, Hyun Sung Ji +19 more
2024Alimentary Pharmacology and Therapeutics19 citations Open access
Semantic Scholar
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery
R. Sakamori, Ryoko Yamada, Y. Tahata, T. Kodama +4 more
2022Journal of gastroenterology16 citations
Semantic Scholar
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma
K. Maesaka, R. Sakamori, Ryoko Yamada, Y. Tahata +6 more
2020Hepatology Research16 citations
Semantic Scholar
Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
K. Shirai, Hayato Hikita, Sadatsugu Sakane, Ryohei Narumi +11 more
2022PLoS ONE15 citations Open access
Semantic Scholar
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD
Sadatsugu Sakane, Hayato Hikita, K. Shirai, Tatsuya Sakamoto +20 more
2024Hepatology Communications14 citations Open access
Semantic Scholar
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study
Machiko Kai, Hayato Hikita, Maesaka Kazuki, Y. Tahata +24 more
2024PLoS ONE14 citations Open access
Semantic Scholar
SIRT1 enhances hepatitis virus B transcription independent of hepatic autophagy.
Takuo Yamai, Hayato Hikita, Makoto Fukuoka, Keisuke Fukutomi +10 more
2020Biochemical and Biophysical Research Communications - BBRC14 citations
Semantic Scholar
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
Junya Okabe, T. Kodama, Yu Sato, Satoshi Shigeno +14 more
2023Journal of experimental & clinical cancer research : CR13 citations Open access
Semantic Scholar
Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy
Kazuhiro Murai, T. Kodama, Hayato Hikita, A. Shimoda +15 more
2022Hepatology Communications13 citations Open access
Semantic Scholar
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis
Y. Tahata, R. Sakamori, K. Maesaka, Akira Doi +18 more
2022Hepatology Research13 citations
Semantic Scholar
Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss
Katsuhiko Sato, Hayato Hikita, Minoru Shigekawa, Seiya Kato +16 more
2022Cancer Science12 citations Open access
Semantic Scholar
Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment
K. Maesaka, R. Sakamori, Ryoko Yamada, Y. Tahata +14 more
2021Hepatology Research10 citations
Semantic Scholar
Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment
Y. Tahata, R. Sakamori, Ayako Urabe, Ryoko Yamada +11 more
2019Hepatology Research10 citations
Semantic Scholar
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
Emi Sometani, Hayato Hikita, Kazuhiro Murai, H. Toyoda +19 more
2024Hepatology Research9 citations Open access
Semantic Scholar
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus
Y. Tahata, Hayato Hikita, S. Mochida, Nobuyuki Enomoto +34 more
2023Journal of gastroenterology9 citations Open access
Semantic Scholar
Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis
Y. Tahata, R. Sakamori, Ryoko Yamada, T. Kodama +20 more
2022Digestive Diseases and Sciences9 citations
Semantic Scholar
Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus–Infected Hepatocytes During Interferon Administration
Keisuke Fukutomi, Hayato Hikita, Kazuhiro Murai, T. Nakabori +12 more
2021Hepatology Communications9 citations Open access
Semantic Scholar
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs
Kazuhiro Murai, Hayato Hikita, Ryoko Yamada, Yuki Nishimura +33 more
2025Hepatology Research8 citations Open access
Semantic Scholar
Liver Sinusoidal Endothelial Cells Promote Metabolic Dysfunction-associated Steatohepatitis Progression via Interleukin-1R1-mediated Chemokine Production Induced by Macrophage-derived Interleukin-1β
K. Fukumoto, Hayato Hikita, Yoshinobu Saito, Yuki Makino +15 more
2025Cellular and Molecular Gastroenterology and Hepatology8 citations
Semantic Scholar
Intrahepatic Exhausted Antiviral Immunity in an Immunocompetent Mouse Model of Chronic Hepatitis B
Satoshi Shigeno, T. Kodama, Kazuhiro Murai, Daisuke Motooka +7 more
2024Cellular and Molecular Gastroenterology and Hepatology8 citations Open access
Semantic Scholar
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Takayuki Matsumae, T. Kodama, Y. Tahata, Yuta Myojin +17 more
2023Cancers8 citations Open access
Semantic Scholar
Efficacy and associated factors of endoscopic transpapillary drainage for postoperative biliary leakage
J. Murata, Minoru Shigekawa, Shuji Ishii, T. Suda +15 more
2023DEN Open8 citations Open access
Semantic Scholar
Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma
K. Maesaka, R. Sakamori, Ryoko Yamada, Y. Tahata +11 more
2021Anticancer Research8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Hayato Hikita×49
Invite
Hayato Hikita — researcher profile on SciRah
T. Kodama×48
Invite
T. Kodama — researcher profile on SciRah
T. Takehara×46
Invite
T. Takehara — researcher profile on SciRah
R. Sakamori×45
Invite
R. Sakamori — researcher profile on SciRah

×33

Invite

Ryoko Yamada — researcher profile on SciRah

Invite

Y. Tahata — researcher profile on SciRah

Invite

K. Ohkawa — researcher profile on SciRah

T. Yakushijin×16

Invite

T. Yakushijin — researcher profile on SciRah

Kazuhiro Murai×16

Invite

Kazuhiro Murai — researcher profile on SciRah

Sadatsugu Sakane×13

Invite

Sadatsugu Sakane — researcher profile on SciRah

Invite

K. Maesaka — researcher profile on SciRah

M. Miyazaki×12

Invite

M. Miyazaki — researcher profile on SciRah